300 related articles for article (PubMed ID: 30677596)
21. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
[TBL] [Abstract][Full Text] [Related]
22. PPAR expression throughout the oestrous cycle in the bovine endometrium.
Socha BM; Łupicka M; Szczepańska AA; Korzekwa AJ
Theriogenology; 2017 Sep; 100():88-94. PubMed ID: 28708539
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor (PPAR) expression in cultured bovine endometrial cells and response to omega-3 fatty acid, growth hormone and agonist stimulation in relation to series 2 prostaglandin production.
MacLaren LA; Guzeloglu A; Michel F; Thatcher WW
Domest Anim Endocrinol; 2006 Mar; 30(3):155-69. PubMed ID: 16154718
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor delta facilitates lipid secretion and catabolism of fatty acids in dairy goat mammary epithelial cells.
Shi HB; Zhang CH; Zhao W; Luo J; Loor JJ
J Dairy Sci; 2017 Jan; 100(1):797-806. PubMed ID: 27865496
[TBL] [Abstract][Full Text] [Related]
25. The influence of arachidonic acid metabolites on PPAR and RXR expression in bovine uterine cells.
Szczepańska AA; Łupicka M; Socha BM; Korzekwa AJ
Gen Comp Endocrinol; 2018 Jun; 262():27-35. PubMed ID: 29510153
[TBL] [Abstract][Full Text] [Related]
26. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
[TBL] [Abstract][Full Text] [Related]
27. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor gamma ligands affect NF-kB and cytokine synthesis in the porcine endometrium-An in vitro study.
Kunicka Z; Kurzynska A; Szydlowska A; Mierzejewski K; Bogacka I
Am J Reprod Immunol; 2019 Jan; 81(1):e13053. PubMed ID: 30265413
[TBL] [Abstract][Full Text] [Related]
29. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor delta regulates lipid droplet formation and transport in goat mammary epithelial cells.
Shi HB; Zhang CH; Xu ZA; Lou GG; Liu JX; Luo J; Loor JJ
J Dairy Sci; 2018 Mar; 101(3):2641-2649. PubMed ID: 29331469
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
32. Cell-type expression, immunolocalization, and deoxyribonucleic acid-binding activity of basic transcription element binding transcription factor, an Sp-related family member, in porcine endometrium of pregnancy.
Wang Y; Michel FJ; Wing A; Simmen FA; Simmen RC
Biol Reprod; 1997 Oct; 57(4):707-14. PubMed ID: 9314570
[TBL] [Abstract][Full Text] [Related]
33. The Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Pan-Cancer.
Huang R; Zhang J; Li M; Yan P; Yin H; Zhai S; Zhu X; Hu P; Zhang J; Huang L; Li M; Sun Z; Meng T; Yang D; Huang Z
PPAR Res; 2020; 2020():6527564. PubMed ID: 33029111
[TBL] [Abstract][Full Text] [Related]
34. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma.
Mössner R; Schulz U; Krüger U; Middel P; Schinner S; Füzesi L; Neumann C; Reich K
J Invest Dermatol; 2002 Sep; 119(3):576-82. PubMed ID: 12230498
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptors and inflammation.
Moraes LA; Piqueras L; Bishop-Bailey D
Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
[TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
Cheng J; Nakamura H; Imanishi H; Liu W; Morisaki T; Sugiyama T; Hada T
Biochem Biophys Res Commun; 2004 Sep; 322(2):458-64. PubMed ID: 15325252
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor isoform expression changes in human gestational tissues with labor at term.
Berry EB; Eykholt R; Helliwell RJ; Gilmour RS; Mitchell MD; Marvin KW
Mol Pharmacol; 2003 Dec; 64(6):1586-90. PubMed ID: 14645690
[TBL] [Abstract][Full Text] [Related]
38. Peroxisome proliferator activated receptor ligands affect progesterone and 17β-estradiol secretion by porcine corpus luteum during early pregnancy.
Kurzynska A; Bogacki M; Chojnowska K; Bogacka I
J Physiol Pharmacol; 2014 Oct; 65(5):709-17. PubMed ID: 25371531
[TBL] [Abstract][Full Text] [Related]
39. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Ichite N; Singh M
Anticancer Drugs; 2007 Jan; 18(1):65-78. PubMed ID: 17159504
[TBL] [Abstract][Full Text] [Related]
40. PPAR agonists modulate human osteoclast formation and activity in vitro.
Chan BY; Gartland A; Wilson PJ; Buckley KA; Dillon JP; Fraser WD; Gallagher JA
Bone; 2007 Jan; 40(1):149-59. PubMed ID: 17010686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
